N1VO34:BVMF
Նովո Նորդիսկ
29,20 R$
0,00%
(0,00) 1D
13 նոյ, 18:07:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for N1VO34...
Open
28,98 R$
High
29,50 R$
Low
28,70 R$
Mkt. cap
142,04 մլրդ
Avg. vol.
27,75 հզր
Volume
34,15 հզր
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 մլրդ
No. of employees
67 հզր
Open
28,98 R$
High
29,50 R$
Low
28,70 R$
Mkt. cap
142,04 մլրդ
Avg. vol.
27,75 հզր
Volume
34,15 հզր
52-wk high
42,43 R$
52-wk low
22,90 R$
Shares outstanding
3,39 մլրդ
No. of employees
67 հզր
News stories
From web sources and news partners
Traders Union
·
13 ժամ առաջ
Novo Nordisk stock rises over 2% as company pledges $200 million to World Diabetes Foundation and lifts guidance
Investing.com
·
1 օր առաջ
Novo Nordisk partners with DJ Khaled for Wegovy campaign
Seeking Alpha
·
1 օր առաջ
Novo Nordisk Stock: Better Than It Looks, But Not A Buy Yet (NYSE:NVO)
The Motley Fool
·
2 օր առաջ
JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?
Profile
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily obesity and diabetes medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 69,500 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
About Նովո Նորդիսկ
CEOMike Doustdar
Employees66,7 հզր
Founded1923
HeadquartersBagsværd, Մայրաքաղաքային տարածաշրջան, Դանիա
SectorHealth Care
Industry-
Websitenovonordisk.com